AIC Expands Infusion Options for Patients with Immunodeficiency
Advanced Infusion Care (AIC), a division of AIS Healthcare, is excited to announce the addition of ALYGLO™, a therapeutic treatment manufactured by GC Biopharma, to its portfolio. This new option will primarily help patients suffering from primary humoral immunodeficiency (PI) in adults. The conditions treated include congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).
Home Infusion Care Enhance Patient Experience
The AIC's nationally accredited home infusion teams are committed to collaborating closely with healthcare providers to deliver specialized infusion services. These services can be provided at home or in a designated infusion suite, significantly improving the treatment experience for patients with PI by offering flexibility and comfort.
Personalized Support for Patients
AIC focuses on high-quality patient care, ensuring that every patient receives tailored services that include 24/7 access to clinical and support staff. All patients have a dedicated team featuring clinical pharmacists, home infusion nurses, and patient access specialists who guide and support them throughout their treatment journeys.
Meeting Patient Needs with Comprehensive Care
At AIC, we believe that providing care means being more than just a specialty pharmacy. We have established partnerships with multiple immunoglobulin suppliers, including GC Biopharma. These collaborations enable AIC to maintain sufficient stock of prescribed therapies, ensuring timely treatment for patients.
Commitment to Excellence in Infusion Therapy
In 2023, the U.S. Food and Drug Administration approved ALYGLO™, which is now accessible at all AIC locations, including Birmingham, AL; Panama City, FL; Cockeysville, MD; Valdosta, GA; and Dallas, TX. This new addition enhances AIC's already robust portfolio of therapies aimed at improving patient outcomes.
A Dedicated Partner for Physicians
For physicians, AIC serves as a complete care delivery partner. We take pride in streamlining patient care by managing all necessary insurance authorizations and approvals directly. Our coordination with healthcare professionals helps ensure that patients receive the best possible treatment experience.
Quality Assurance Through Accreditation
AIS Healthcare holds dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), which distinguishes it from many other infusion care providers. This accreditation is a testament to our commitment to quality and enhanced patient safety in all services we provide.
About AIS Healthcare
AIS Healthcare is recognized as a leader in infusion care solutions and targeted drug delivery. The company's mission focuses on advancing quality and improving patient lives through better healthcare services. AIS Healthcare continually strives to offer innovative treatments and comprehensive care that puts patient safety at the forefront.
About GC Biopharma
GC Biopharma stands as a global biopharmaceutical company committed to delivering high-quality specialty pharmaceuticals. Since manufacturing its first plasma-derived therapy in South Korea in 1971, GC Biopharma has expanded its reach to over 50 countries, emphasizing the development of plasma-derived drug products with a vision for a healthier world. Its dedication to innovation has made it one of the top manufacturers in the industry.
Frequently Asked Questions
What is ALYGLO™ used for?
ALYGLO™ is intended for treating patients with primary humoral immunodeficiency, addressing various immune deficiencies.
How does AIC support patients undergoing treatment?
AIC provides 24/7 support, assigning dedicated clinical teams to assist patients throughout their treatment journey.
Where can I access ALYGLO™?
ALYGLO™ is available at all AIC locations across several states, ensuring broad access for patients in need.
What sets AIC apart as an infusion care provider?
AIC's dual accreditation and partnerships with multiple suppliers distinguish it as a leader in quality infusion care.
What is the history of GC Biopharma?
Founded in 1971, GC Biopharma has evolved into a prominent biopharmaceutical company focused on plasma-derived therapies, expanding its impact globally.
